Highland Capital Management (Tennessee)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.4M Buy
34,630
+265
+0.8% +$127K 0.8% 23
2026
Q1
$16.9M Buy
34,365
+226
+0.7% +$123K 0.89% 21
2025
Q4
$19.8M Sell
34,139
-686
-2% -$388K 0.98% 19
2025
Q3
$16.9M Sell
34,825
-73
-0.2% -$34K 0.84% 21
2025
Q2
$14.1M Sell
34,898
-108
-0.3% -$45.2K 0.77% 23
2025
Q1
$17.4M Buy
35,006
+1,027
+3% +$556K 1.04% 18
2024
Q4
$17.7M Buy
33,979
+3,102
+10% +$1.71M 1.01% 18
2024
Q3
$19.1M Sell
30,877
-489
-2% -$289K 1.09% 17
2024
Q2
$17.3M Sell
31,366
-391
-1% -$224K 1.02% 18
2024
Q1
$18.5M Buy
31,757
+63
+0.2% +$35.4K 1.06% 17
2023
Q4
$16.8M Sell
31,694
-1,089
-3% -$527K 1.04% 16
2023
Q3
$16.6M Sell
32,783
-834
-2% -$444K 1.14% 17
2023
Q2
$17.5M Sell
33,617
-444
-1% -$240K 1.14% 17
2023
Q1
$19.6M Sell
34,061
-1,730
-5% -$975K 1.45% 9
2022
Q4
$19.7M Sell
35,791
-591
-2% -$313K 1.39% 7
2022
Q3
$18.5M Buy
36,382
+6
+0% +$3.36K 1.43% 11
2022
Q2
$19.8M Sell
36,376
-933
-3% -$514K 1.42% 10
2022
Q1
$22M Buy
37,309
+8,437
+29% +$4.85M 1.32% 12
2021
Q4
$19.3M Sell
28,872
-2,731
-9% -$1.71M 1.09% 16
2021
Q3
$18.1M Sell
31,603
-371
-1% -$204K 1.1% 14
2021
Q2
$16.1M Sell
31,974
-4,005
-11% -$1.89M 0.96% 24
2021
Q1
$16.4M Sell
35,979
-7,206
-17% -$3.44M 1.01% 23
2020
Q4
$20.1M Buy
43,185
+773
+2% +$362K 1.29% 11
2020
Q3
$18.7M Sell
42,412
-665
-2% -$275K 1.34% 11
2020
Q2
$15.6M Buy
43,077
+475
+1% +$159K 1.22% 15
2020
Q1
$12.1M Buy
42,602
+840
+2% +$265K 1.14% 16
2019
Q4
$13.6M Sell
41,762
-1,341
-3% -$407K 0.94% 24
2019
Q3
$12.6M Buy
43,103
+5,881
+16% +$1.68M 0.93% 26
2019
Q2
$10.9M Sell
37,222
-13
-0% -$3.58K 0.81% 28
2019
Q1
$10.2M Sell
37,235
-89
-0.2% -$22.1K 0.77% 33
2018
Q4
$8.35M Sell
37,324
-5,312
-12% -$1.25M 0.71% 38
2018
Q3
$10.4M Buy
42,636
+3,236
+8% +$744K 0.75% 38
2018
Q2
$8.16M Buy
39,400
+67
+0.2% +$14.2K 0.62% 43
2018
Q1
$8.12M Buy
39,333
+587
+2% +$123K 0.63% 43
2017
Q4
$7.36M Sell
38,746
-314
-0.8% -$60.2K 0.56% 52
2017
Q3
$7.39M Sell
39,060
-373
-0.9% -$67.6K 0.59% 47
2017
Q2
$6.88M Buy
39,433
+1,756
+5% +$295K 0.55% 52
2017
Q1
$5.79M Sell
37,677
-16
-0% -$2.45K 0.48% 66
2016
Q4
$5.32M Buy
37,693
+1,394
+4% +$206K 0.45% 77
2016
Q3
$5.77M Sell
36,299
-2,509
-6% -$387K 0.49% 62
2016
Q2
$5.73M Sell
38,808
-4,082
-10% -$602K 0.5% 64
2016
Q1
$6.07M Sell
42,890
-20,441
-32% -$2.74M 0.52% 61
2015
Q4
$8.98M Sell
63,331
-16,471
-21% -$2.2M 0.72% 39
2015
Q3
$9.76M Buy
79,802
+278
+0.3% +$36.2K 0.82% 31
2015
Q2
$10.3M Buy
79,524
+27,824
+54% +$3.63M 0.79% 26
2015
Q1
$6.95M Buy
51,700
+1,020
+2% +$131K 1.36% 25
2014
Q4
$6.35M Buy
50,680
+75
+0.1% +$9.12K 1.19% 29
2014
Q3
$6.16M Sell
50,605
-160
-0.3% -$19.5K 1.21% 29
2014
Q2
$5.99M Sell
50,765
-3,615
-7% -$425K 1.12% 34
2014
Q1
$6.54M Sell
54,380
-1,035
-2% -$123K 1.27% 28
2013
Q4
$6.17M Sell
55,415
-70
-0.1% -$6.96K 1.23% 33
2013
Q3
$5.11M Sell
55,485
-235
-0.4% -$21.3K 1.13% 36
2013
Q2
$4.72M Buy
+55,720
New +$4.64M 1.07% 38

Other funds holding TMO

Highland Capital Management (Tennessee)'s TMO Position: Q2 2026 in Review

Highland Capital Management (Tennessee) increased its Thermo Fisher Scientific (TMO) stake by 0.77% in Q2 2026, buying an estimated $127K and bringing the position to 34,630 shares worth $17.4M. The position accounts for 0.8% of the portfolio, ranked #23.

Highland Capital Management (Tennessee) first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $22M in Q1 2022. 1,244 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Highland Capital Management (Tennessee) held 34,630 shares of Thermo Fisher Scientific worth $17.4M as of Q2 2026.
  • Highland Capital Management (Tennessee) bought 265 Thermo Fisher Scientific shares in Q2 2026, an estimated $127K.
  • Thermo Fisher Scientific made up 0.8% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #23 holding.
  • Highland Capital Management (Tennessee) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
  • Highland Capital Management (Tennessee)'s Thermo Fisher Scientific position peaked at $22M in Q1 2022.
  • 1,244 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.